Can Neutrophil‐to‐Lymphocyte Ratio, Monocyte‐to‐Lymphocyte Ratio, and Platelet‐to‐Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?

Background Recent reports have showed that neutrophil‐to‐lymphocyte ratio ( NLR ), platelet‐to‐lymphocyte ratio ( PLR ), and monocyte‐to‐lymphocyte ratio ( MLR ) are predictors of progression‐free survival ( PFS ) and overall survival ( OS ) in many types of cancer. This study evaluates the predictive value of NLR , MLR , and PLR for survival in MM patients treated with to ASCT . Methods A set of data consisting of 150 patients who underwent...